GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CRH Medical Corp (AMEX:CRHM) » Definitions » Price-to-Owner-Earnings

CRH Medical (CRH Medical) Price-to-Owner-Earnings : 49.88 (As of Apr. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is CRH Medical Price-to-Owner-Earnings?

As of today (2024-04-25), CRH Medical's share price is $3.99. CRH Medical's Owner Earnings per Share (TTM) ended in Dec. 2020 was $0.08. It's Price-to-Owner-Earnings for today is 49.88.


The historical rank and industry rank for CRH Medical's Price-to-Owner-Earnings or its related term are showing as below:

CRHM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.48   Med: 14.8   Max: 4200
Current: 47.98

During the past 13 years, the highest Price-to-Owner-Earnings of CRH Medical was 4200.00. The lowest was 2.48. And the median was 14.80.


CRHM's Price-to-Owner-Earnings is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 31.79 vs CRHM: 47.98

As of today (2024-04-25), CRH Medical's share price is $3.99. CRH Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.34. Therefore, CRH Medical's PE Ratio for today is At Loss.

As of today (2024-04-25), CRH Medical's share price is $3.99. CRH Medical's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.34. Therefore, CRH Medical's PE Ratio without NRI for today is At Loss.

During the past 13 years, CRH Medical's highest PE Ratio without NRI was 267.50. The lowest was 0.00. And the median was 38.73.


CRH Medical Price-to-Owner-Earnings Historical Data

The historical data trend for CRH Medical's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CRH Medical Price-to-Owner-Earnings Chart

CRH Medical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.00 5.64 8.47 6.43 29.13

CRH Medical Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.43 2.79 4.06 4.43 29.13

Competitive Comparison of CRH Medical's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, CRH Medical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CRH Medical's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CRH Medical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where CRH Medical's Price-to-Owner-Earnings falls into.



CRH Medical Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

CRH Medical's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=3.99/0.08
=49.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CRH Medical  (AMEX:CRHM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


CRH Medical Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of CRH Medical's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


CRH Medical (CRH Medical) Business Description

Traded in Other Exchanges
N/A
Address
999 Canada Place, Suite 578, World Trade Center, Vancouver, BC, CAN, V6C 3E1
CRH Medical Corp is a healthcare products and services company. The company, through its subsidiaries, provides anesthesiology services to gastroenterologists in the United States. It also specializes in the treatment of hemorrhoids utilizing its treatment protocol and patented proprietary technology. The company's product, the CRH O'Regan System, is a single-use, disposable, hemorrhoid treatment. It distributes the CRH O'Regan System, treatment protocols, operational and marketing services directly to gastroenterologists. Geographically, the company operates in the United States and Canada, of which key revenue is derived from the United States.
Executives
Richard Bear officer: Chief Financial Officer 9062 NE 37TH PLACE, BELLEVUE WA 98004
Ian Webb director 7385 LABURNUM ST VANCOUVER A1 V6P 5N2
James Kreger officer: President 2580 ACORN AVE NE ATLANTA GA 30305
Tushar M Ramani director, officer: Chief Executive Officer 118 TALAVERA PLACE PALM BEACH GARDENS FL 33418
Brian T Griffin director
Todd Patrick director 9029 NE 36TH STREET, BELLEVUE WA 98004
David Allan Johnson director 7464 NORTH SHORE ROAD NORFOLK VA 23505
Anthony F Holler director 8855 NORTHBROOK CT BURNABY A1
Edward Wright officer: Chief Financial Officer 2992 WEST 31ST AVE VANCOUVER A1 V6L 2A4